Results for
Israeli AI FemTech solution secures prestigious US cancer grant to advance women s health
The Israeli FemTech startup earns a prestigious grant from the National Cancer Institute, as an innovator in the battle against cancer. Dor Schwartz / 25 Jan 2021 • 2 min read
MobileODT, an Israeli FemTech startup focusing on AI-powered cervical screening, has caught the eye of the US National Cancer Institute (NCI), with the NCI awarding Mobile ODT with a $2.3 million grant. The Small Business Innovation Research Authority grant is given by the NCI to companies that are technologically and clinically reducing the suffering from cancer. We are honored to receive such a prestigious grant, especially from National Cancer Institute. It s a recognition of the value that our technology is bringing to women s health, said Leon Boston, MobileODT CEO.
There s another reason to keep your tippling to a moderate level: Alcohol plays a significant role in cancer cases and deaths in the United States, researchers say.
Author summary Visceral leishmaniasis (VL) remains a worldwide health issue, with increasing rates of mortality being observed. Brazil has an epidemiological scenario of expanding VL transmission, especially in the Northeast region. In the present study, we analysed spatiotemporal dynamics of VL cases and its association with social vulnerability in Brazilian Northeast. Briefly, data was analysed of all VL confirmed cases during the years of 2000 to 2017 and the Social Vulnerability Index (SVI) from 1,794 municipalities of Brazilian Northeast. Results revealed that VL continues to spread heterogeneously, with space-time high-risk clusters in the most socially vulnerable areas. We observed increasing trends of new cases among male subjects ≥ 40 years of age and urban residents. Our study represents the first investigation that demonstrates associations between VL and social vulnerability in the Northeast region of Brazil. These findings could contribute to VL prevention, surveillance
Study reveals significant role of ADAMTS1 protein in uveal melanoma
Scientists from the University of Granada and GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), in a study led by Juan Carlos Rodríguez-Manzaneque, have demonstrated the significant role of a protein called ADAMTS1 in uveal melanoma, one of the rarest and most aggressive cancers that exist, which develops in the eye.
tumors are composed not only of a mass of cells that grow uncontrollably but also of the environment they create during their growth together creating what is known as the tumor microenvironment . Within this environment, there are proteins that remodel it, known as extracellular proteases, which are capable of inhibiting or contributing to tumor growth and metastasis. They do this by modifying non-cellular elements of the tumor microenvironment that form the so-called extracellular matrix.